Physician profile
Ashley E Berry
NPI 1720364458
$1,035.32
in general payments reported to CMS, 2019-2025
21 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $150 · 2023: $314 · 2024: $222 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $885.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $256.27 | 2022-2025 | Auvelity |
| Abbvie INC. | $114.71 | 2022-2025 | |
| Vanda Pharmaceuticals INC. | $110.49 | 2024-2025 | Fanapt, Hetlioz |
| Novo Nordisk INC | $91.25 | 2022-2025 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $54.96 | 2022-2024 | Vaxneuvance, Gardasil 9, Capvaxive |
| Corium, LLC | $48.44 | 2023-2025 | Azstarys |
| Glaxosmithkline, LLC. | $47.53 | 2023-2024 | Bexsero |
| Janssen Pharmaceuticals, INC | $44.25 | 2024-2025 | Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $41.69 | 2025 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $36.85 | 2024-2025 | Farxiga |
| Lilly USA, LLC | $28.50 | 2022-2023 | Jardiance |
| Alkermes, INC. | $21.89 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.81 | 2022 | |
| Pfizer INC. | $17.25 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.64 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.06 | 2024 | Jardiance |
| Sage Therapeutics, LLC | $15.75 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $14.63 | 2025 | Qelbree |
| Otsuka America Pharmaceutical, INC. | $13.76 | 2024 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $13.59 | 2024 | |
| Exact Sciences Corporation | $13.00 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.